Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Petrol Diesel Prices
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
India

DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG

DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
Written by Pratyush Deep Kotoky
Jul 09, 2021, 03:01 am 3 min read
DRDO nod for Mankind Pharma to manufacture COVID-19 drug 2-DG
Mankind Pharma will be manufacturing 2-DG at its facilities in Visakhapatnam and Himachal Pradesh.

Pharmaceutical firm Mankind Pharma on Thursday announced that it has received approval from the Defence Research and Development Organisation (DRDO) to manufacture and market the COVID-19 drug 2-Deoxy-D-Glucose or 2-DG. The drug was developed by Defence Research Development Establishment (DRDE), Gwalior, and clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr. Reddy's Laboratories.

Statement
Aim is to ensure maximum reach of drug: Mankind Pharma

Mankind Pharma, popular for its brands Manforce and Prega News, said in a statement on Thursday that it will manufacture the anti-COVID-19 drug at its facilities in Visakhapatnam and Himachal Pradesh. The company said, "Our objective behind this agreement is to ensure maximum reach of this medication to the deserving Indian patients suffering from the deadly pandemic."

Drug
How effective is the drug against COVID-19?

2-DG helps in the recovery of hospitalized patients and is recommended for moderate to severe COVID-19 patients under a physician's supervision as an adjunct therapy. It selectively accumulates in virus-infected cells and stops viral synthesis and energy production. The drug also alleviates cells from infection-induced cytopathic effects and cell death. It helps patients recover faster and reduces their dependence on supplemental oxygen.

Manufacture
Apart from Mankind Pharma, who else is manufacturing the drug?

Apart from Mankind Pharma, other companies such as Laurus Labs, Bajaj Healthcare have also received approvals to manufacture the drug. Another drugmaker, Shilpa Medicare, has also announced that it had received in-principle approval from DRDO. According to officials, since the drug is a generic molecule and analog of glucose, it can be easily produced and can be made available in plenty.

Price
How much will it cost?

The drug comes in powder form in a sachet and can be taken orally by dissolving it in water. Reportedly, the drug will be available in the market at a fixed price of Rs. 990. However, the DRDO will provide the drug for free to state and central governments. Notably, Dr. Reddy's has been producing the drug in limited quantity for hospitals.

Prescription
Drug can be only used to treat moderate-severe patients

2-DG, which was given approval for emergency use on May 1, can only be used to treat moderate to severe COVID-19 patients. While the drug is strictly prohibited to pregnant and lactating women and patients under 18 years, people with uncontrolled diabetes, cardiac problems, ARDS, severe hepatic and renal impairment are also advised to take caution before taking the drug.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Pratyush Deep Kotoky
Pratyush Deep Kotoky
Twitter
Pratyush Deep Kotoky covers national and politics news at NewsBytes. His over three-year-long career involves reporting on sociopolitical issues across India, particularly the northeast region. His previous stints include 101Reporters, The Sunday Guardian, and Inshorts, and he has also written for Asia Times, Firstpost, and Newslaundry. He has a postgraduate degree in Journalism from the Indian Institute of Mass Communication, Delhi.
Latest
Defence Research and Development Organisation (DRDO)
Drugs Controller General of India
Coronavirus
Related
Latest
Real Madrid win UEFA Champions League 2021-22 final: Records broken
Real Madrid win UEFA Champions League 2021-22 final: Records broken Sports
Suzuki Vision Gran Turismo revealed with Hayabusa engine, all-wheel-drive
Suzuki Vision Gran Turismo revealed with Hayabusa engine, all-wheel-drive Auto
Champions League final: 0-0 between Liverpool and Real at half-time
Champions League final: 0-0 between Liverpool and Real at half-time Sports
Honda CB400 Super Four, Bol d'Or Final Edition go official
Honda CB400 Super Four, Bol d'Or Final Edition go official Auto
CUBOT Pocket with 4-inch QHD+ display and NFC goes official
CUBOT Pocket with 4-inch QHD+ display and NFC goes official Technology
Defence Research and Development Organisation (DRDO)
Indian Air Force, Navy partner with DRDO for chaff technology
Indian Air Force, Navy partner with DRDO for chaff technology India
DRDO successfully test-fires medium-range surface-to-air missile, destroys target
DRDO successfully test-fires medium-range surface-to-air missile, destroys target India
India flight tests new generation surface-to-air Akash missile
India flight tests new generation surface-to-air Akash missile India
COVID-19 drug 2-DG launched: All you need to know
COVID-19 drug 2-DG launched: All you need to know India
DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered
DRDO's anti-coronavirus drug: Its efficacy, price, and more queries answered India
More News
Drugs Controller General of India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Related
COVID-19: India reports 90K+ cases; Omicron tally crosses 2,600
COVID-19: India reports 90K+ cases; Omicron tally crosses 2,600 India
COVID-19: India records 33K+ cases; Omicron tally reaches 1,700
COVID-19: India records 33K+ cases; Omicron tally reaches 1,700 India
COVID-19: India reports 6K+ infections; 213 Omicron cases
COVID-19: India reports 6K+ infections; 213 Omicron cases India
COVID-19: India reports 8K+ infections; 621 more deaths
COVID-19: India reports 8K+ infections; 621 more deaths India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022